Top compounds associated with response to LCORL


Feature Type Standardized
Nominal ANOVA
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC 0.1 0.001
mRNA PD-0325901 GDSC1000 pan-cancer AAC -0.11 0.001
mRNA CHEMBL1222381 CTRPv2 pan-cancer AAC 0.11 0.001
mRNA Rapamycin gCSI pan-cancer AAC 0.18 0.001
mRNA erlotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 0.001
mRNA 16-beta-bromoandrosterone CTRPv2 pan-cancer AAC 0.12 0.001
mRNA VX-11e GDSC1000 pan-cancer AAC -0.11 0.001
mRNA JNJ-26854165 CTRPv2 pan-cancer AAC 0.11 0.001
mRNA RG-108 CTRPv2 pan-cancer AAC 0.12 0.002
mRNA Cytarabine CTRPv2 pan-cancer AAC 0.091 0.002
Download CSV